VergerC., CelicoutB., LarpentL., GoupilA.Péritonite encapsulante au cours de dialyse péritonéale continue ambulatoire. Hypothése Physiopathologique.Presse Med1986; 15: 1311–14.
3.
SlingeneyerA., MionC., MouradG., CanaudB., FallerB., BéraudJ.J.Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis.ASAIO Trans1983; 29: 633–40.
MachadoD.J.B., RomãoJ.E.Jr., SabbagaE., MachadoM.M., AbensurH.Peritonite esclerosante e encapsulante secundária à diálise peritoneal ambulatorial contínua.J Bras Nefrol1999; 21: 112–23.
6.
JunorB.J.R., and McMillanM.A.Immunosuppression in sclerosing peritonitis.Adv Perit Dial1993; 9: 187–9.
7.
BhandariS., WilkinsonA., IellarsL.Sclerosing peritonitis: Value of immunosuppression prior to surgery.Nephrol Dial Transplant1994; 9: 436–7.
8.
HawleyC.M., WallD.R., JohnsonD.W., CampbellS.B., GriffinA.D., RigbyR.J.Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.Am J Kidney Dis1995; 26: 658–61.
9.
SelgasR., BajoM.A., Del PesoG., JimenezC.Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients.Semin Dial1995; 8: 326–32.
RigbyR.J., and MawleyC.Sclerosing peritonitis: The experience in Australia.Nephrol Dial Transplant1998; 13: 154–9.
12.
ShaldonS., DinarelloC.A., WylerD.J.Induction of interleukin-1 during CAPD.Contrib Nephrol1987; 57: 207–12.
13.
ShinG., KhannaA., DingR., SharmaV.K., LagmanM., LiB.In vivo expression of transforming growth factor-β1 in humans — stimulation by cyclosporine.Transplantation1998; 65: 313–18.
